312 related articles for article (PubMed ID: 34440674)
1. Mitochondrial Metabolic Signatures in Hepatocellular Carcinoma.
Lee HY; Nga HT; Tian J; Yi HS
Cells; 2021 Jul; 10(8):. PubMed ID: 34440674
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial UQCC3 Modulates Hypoxia Adaptation by Orchestrating OXPHOS and Glycolysis in Hepatocellular Carcinoma.
Yang Y; Zhang G; Guo F; Li Q; Luo H; Shu Y; Shen Y; Gan J; Xu L; Yang H
Cell Rep; 2020 Nov; 33(5):108340. PubMed ID: 33147459
[TBL] [Abstract][Full Text] [Related]
3. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma.
Jin M; Wang J; Ji X; Cao H; Zhu J; Chen Y; Yang J; Zhao Z; Ren T; Xing J
J Exp Clin Cancer Res; 2019 Mar; 38(1):136. PubMed ID: 30909929
[TBL] [Abstract][Full Text] [Related]
4. MCU-dependent mitochondrial Ca
Ren T; Zhang H; Wang J; Zhu J; Jin M; Wu Y; Guo X; Ji L; Huang Q; Zhang H; Yang H; Xing J
Oncogene; 2017 Oct; 36(42):5897-5909. PubMed ID: 28650465
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma.
Hsu CC; Lee HC; Wei YH
World J Gastroenterol; 2013 Dec; 19(47):8880-6. PubMed ID: 24379611
[TBL] [Abstract][Full Text] [Related]
6. Multifaceted roles of aerobic glycolysis and oxidative phosphorylation in hepatocellular carcinoma.
Zhang Y; Li W; Bian Y; Li Y; Cong L
PeerJ; 2023; 11():e14797. PubMed ID: 36748090
[TBL] [Abstract][Full Text] [Related]
7. Increased Oxidative Phosphorylation Is Required for Stemness Maintenance in Liver Cancer Stem Cells from Hepatocellular Carcinoma Cell Line HCCLM3 Cells.
Liu G; Luo Q; Li H; Liu Q; Ju Y; Song G
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722385
[TBL] [Abstract][Full Text] [Related]
8. Lappaconitine Sulfate Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Reactive Oxygen Species-Dependent Mitochondrial Pathway.
Zhang X; Ma J; Song N; Guo Y; Hui L; Sang C
Pharmacology; 2020; 105(11-12):705-714. PubMed ID: 32062649
[TBL] [Abstract][Full Text] [Related]
9. Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes.
Egnatchik RA; Leamy AK; Noguchi Y; Shiota M; Young JD
Metabolism; 2014 Feb; 63(2):283-95. PubMed ID: 24286856
[TBL] [Abstract][Full Text] [Related]
10. Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma.
Zhao C; Wang B; Liu E; Zhang Z
Cell Commun Signal; 2020 Aug; 18(1):131. PubMed ID: 32831114
[TBL] [Abstract][Full Text] [Related]
11. Global changes to HepG2 cell metabolism in response to galactose treatment.
Skolik RA; Solocinski J; Konkle ME; Chakraborty N; Menze MA
Am J Physiol Cell Physiol; 2021 May; 320(5):C778-C793. PubMed ID: 33439775
[TBL] [Abstract][Full Text] [Related]
12. Mitoribosomal defects aggravate liver cancer via aberrant glycolytic flux and T cell exhaustion.
Song BS; Moon JS; Tian J; Lee HY; Sim BC; Kim SH; Kang SG; Kim JT; Nga HT; Benfeitas R; Kim Y; Park S; Wolfe RR; Eun HS; Shong M; Lee S; Kim IY; Yi HS
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580931
[TBL] [Abstract][Full Text] [Related]
13. CRIF1 overexpression facilitates tumor growth and metastasis through inducing ROS/NFκB pathway in hepatocellular carcinoma.
Chang H; Li J; Qu K; Wan Y; Liu S; Zheng W; Zhang Z; Liu C
Cell Death Dis; 2020 May; 11(5):332. PubMed ID: 32382077
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial fission forms a positive feedback loop with cytosolic calcium signaling pathway to promote autophagy in hepatocellular carcinoma cells.
Huang Q; Cao H; Zhan L; Sun X; Wang G; Li J; Guo X; Ren T; Wang Z; Lyu Y; Liu B; An J; Xing J
Cancer Lett; 2017 Sep; 403():108-118. PubMed ID: 28624623
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Romo1 promotes production of reactive oxygen species and invasiveness of hepatic tumor cells.
Chung JS; Park S; Park SH; Park ER; Cha PH; Kim BY; Chung YM; Woo SR; Han CJ; Kim SB; Suh KS; Jang JJ; Lee K; Choi DW; Lee S; Lee GY; Hahm KB; Shin JA; Kim BS; Noh KH; Kim TW; Lee KH; Yoo YD
Gastroenterology; 2012 Oct; 143(4):1084-94.e7. PubMed ID: 22749933
[TBL] [Abstract][Full Text] [Related]
16. Endoplasmic Reticulum Stress Signaling and the Pathogenesis of Hepatocarcinoma.
Wei J; Fang D
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670323
[TBL] [Abstract][Full Text] [Related]
17. Hepatic peroxisome proliferator-activated receptor γ coactivator 1β drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression in mice.
Piccinin E; Peres C; Bellafante E; Ducheix S; Pinto C; Villani G; Moschetta A
Hepatology; 2018 Mar; 67(3):884-898. PubMed ID: 28857232
[TBL] [Abstract][Full Text] [Related]
18. Energy metabolism determines the sensitivity of human hepatocellular carcinoma cells to mitochondrial inhibitors and biguanide drugs.
Hsu CC; Wu LC; Hsia CY; Yin PH; Chi CW; Yeh TS; Lee HC
Oncol Rep; 2015 Sep; 34(3):1620-8. PubMed ID: 26133123
[TBL] [Abstract][Full Text] [Related]
19. NAFLD Related-HCC: The Relationship with Metabolic Disorders.
Zhang X
Adv Exp Med Biol; 2018; 1061():55-62. PubMed ID: 29956206
[TBL] [Abstract][Full Text] [Related]
20. Decrease of MLK4 prevents hepatocellular carcinoma (HCC) through reducing metastasis and inducing apoptosis regulated by ROS/MAPKs signaling.
Li Y; Zuo H; Wang H; Hu A
Biomed Pharmacother; 2019 Aug; 116():108749. PubMed ID: 31071576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
